AZADIRACHTIN, CARDIOFOLIOSIDE AND KUTKIN CAN BE VITAL PHYTOCHEMICALS FOR THE MODULATION OF SECRETASE ENZYMES FOR THE TREATMENT OF ALZHEIMER’S: AN IN-SILICO ANALYSIS

  • Prashant Anthwal Dept. of Biotechnology, Graphic Era University, Dehradun, Uttarakhand, India, 248002

Abstract

Objective:The aim of this study was to screen for active components from medicinal plants of Uttarakhand that has potential for a therapeutic agent for AD by targetingthe secretase enzyme using in-silico approach.

 

Methods:  We used iGEMDOCK for in-silicodocking experiments to screen for active components from medicinal plant, can modulate secretase enzyme. Binding energies for active component from 112 medicinal plants were analyzed.

 

Results:  Our in-silicoanalysis suggests that Cardiofolioside, Azadirachtin, Berberine and Kutkin can best possible candidates for modulation of secretase enzyme and thus hold potential to help patients with AD. The results obtained clearly suggeststhat these active components from plants herbal have the ability to modulate α and β-secretase either as an activator of α-secretase or as an inhibitor of β-secretase when compared with known standard drug.

 

Conclusion:  Cardiofolioside, Azadirachtin, Berberine and Kutkin can acts as a modulator for secretase enzymes and these phytochemicals can be exploited for their potential to that of AD.

References

[1] Khan Zu, Martin Montanez E, NavarroLI, Muly EC: Memory defects in aging and neurological diseases.ProgMolbioTranslSci 2014; 122: 1-29.
[2] Alzheimer’s Disease International, World Alzheimer report: Dementia and Risk Reduction, London, UK 2014.
[3] Alzheimer’s association: Alzheimer’s disease fact and figures. Alzheimer’s association report, Alzheimer’s& Dementia 2013; 9: 208–245.
[4] Hebert LE, Weuve J, Scherr PA et al, Alzheimer’s Disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013. 7-80. 1778-83.
[5] Plassman BL, Langa KM, and Fisher GGet al. Prevalence of Dementia in the United States: he aging, demographics and memory study 2007;. 29: 125-132.
[6] Purohit DP, Batheja NO, Sano M, Jashnani KD, Kalaria RJ, Karunamurthy A et al.:
Profiles of Alzheimer's Disease-Related Pathology in an Aging Urban Population Sample.J
of Alzheimer’s Dis 2011; 24: 187-196.
[7] Mikulca JA,Nguyen V, Gajdosik DA, Teklu SG, Giunta EA, Lessa EA, et al. Potential novel targets for Alzheimer’s pharmacotherapy: Update on secretase inhibitors and related approaches. J of clinical pharm and therap, 2014; 39: 25-37.
[8]Gerald Z and Ockert W: Aggregate sales forecast by active pharmaceutical ingredient in the top seven developed markets.Nat revi d dis 2013; 12: 19-20.
[9] Dubey GP, Agarwal A, Dubey N, Dubey S, Dubey R, Deborah SM: Role of an herbal formulation in the prevention and management of age related neurodegenerative disorders with special reference to senile Dementia. Publication number US20120034324A1, 2012.
[10] Semwal P, Kapoor T, Anthwal P, Sati B, Thapliyal A: Herbal extract as a potential modulator or drug for synaptic plasticity and neurodegenerative disorders. Int J Pharm Sci Rev Res 2014; 25(1): 69-79.
[11] Hsu KC, Chen YF, Lin SR, Yang JM: iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis, BMC Bioinfo2011; 12(1): 1-11.

[12] Kapoor T, Semwal P, Anthwal P, Thapliyal M, Thapliyal A: Quercetin, Bergapten and Barberineb as analogues of Rifampicin and Isoniazid screened in silico from herbal plants of Uttarakhand for the treatment of Tuberculosis (TB), Biotech Inter 2013; 6(4): 48-57.

[13] Semwal P, Tripathi R, thapliyal A: Herbal active components act as inhibitor against HCV
NS3/4A protease by using bioinformatics approach.Drug Disco 2015; 10 (23): 15-21.

[14] Balavignesh V, Srinivasan E, RameshNGB and Saravanan N:Molecular Docking study on
NS5B polymerase of Hepatitis c virus by screening of volatile compounds from Acacia
concinna andADMET prediction. Inte J of Phar and L Sci 2013; 4(4): 2548-2558.
[15] Shimmyo Y, Khihara T, Akaike A, Niidome T, Sugimoto H: Multifunction of Myrecitin on Abeta: Neuroprotection via a conformational change of Abeta and reduction of Abeta via the interference of secretases, J of Neurosci Res 2008; 86 (2): 368 -77.
[16] Chakraborty S, Kumar S, BAsu S: Conformational transition in the structure binding domain of Beta secretase exploited by its NMR and its implication in inhibitor recognition: BACE1- Myrecitin a case study.Neuroche Intern 2011;58(8): 914-23.
[17] Patil SP, Maki S, Khedkar SA, Rigby AC, Chan C:Withanolide A nad Asiatic acid Modulate Multiple targets associated with Amyloid-β Precursor Protein Processing and Amyloid-β Protein clearance. J of NatPro2010; 73(7): 1196-1202.
[18] Son TG, Camondela S, Arumugam TV, Cutler RG, Telljohann RS, Mughal MR:Plumbagin a Novel Nrf2/ARE2 Activator Protects Against cerebral Ischemia. J of Neuroche 2010; 112(5):1316-1326.
[19] Bramanti E, Lenci F, Sgarbossa S: Effects of Hypericin on the structure and aggregation properties of Beta –Amyloid Peptides. Biophy of Struc and Mech 2010; 39 (11): 1493-501.
Statistics
239 Views | 326 Downloads
How to Cite
Anthwal, P. “AZADIRACHTIN, CARDIOFOLIOSIDE AND KUTKIN CAN BE VITAL PHYTOCHEMICALS FOR THE MODULATION OF SECRETASE ENZYMES FOR THE TREATMENT OF ALZHEIMER’S: AN IN-SILICO ANALYSIS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 4, July 2015, pp. 108-12, https://innovareacademics.in/journals/index.php/ajpcr/article/view/5954.
Section
Original Article(s)